Skip to contentNovo A/S — BIOMIMETIC THERAPEUTICS, INC. insider: 903 transactions · InsiderLensNovo A/S
- 10% owner at Metagenomi Therapeutics, Inc. · on record since Feb 15, 2024
- 10% owner at BIOMIMETIC THERAPEUTICS, INC. · on record since Feb 2, 2007
- 10% owner at MapLight Therapeutics, Inc. · on record since Oct 30, 2025
- 10% owner at CYTEC INDUSTRIES INC/DE/ · on record since Jun 23, 2021
- 10% owner at Verve Therapeutics, Inc. · on record since Jun 22, 2021
- 10% owner at KalVista Pharmaceuticals, Inc. · on record since Nov 30, 2016
- 10% owner at Avalyn Pharma Inc. · on record since Apr 29, 2026
- 10% owner at Hemab Therapeutics Holdings, Inc. · on record since Apr 30, 2026
- 10% owner at iRhythm Holdings, Inc. · on record since Oct 26, 2016
- 10% owner at Ra Pharmaceuticals, Inc. · on record since Oct 25, 2016
- 10% owner at Flexion Therapeutics Inc · on record since Dec 18, 2014
- 10% owner at INTROGEN THERAPEUTICS INC · on record since Oct 17, 2014
- 10% owner at Ophthotech Corp. · on record since Nov 17, 2014
- 10% owner at OnKure Therapeutics, Inc. · on record since Apr 14, 2021
- 10% owner at CoLucid Pharmaceuticals, Inc. · on record since May 12, 2015
- 10% owner at HTG MOLECULAR DIAGNOSTICS, INC · on record since May 12, 2015
- 10% owner at Regado Biosciences Inc · on record since May 6, 2015
- 10% owner at Corvus Pharmaceuticals, Inc. · on record since Mar 30, 2016
- 10% owner at REATA PHARMACEUTICALS INC · on record since May 25, 2016
- 10% owner at ANAPTYSBIO, INC · on record since Jan 25, 2017
- 10% owner at Apollo Entertainment Group, Inc. · on record since Jan 4, 2017
- 10% owner at Entasis Therapeutics Holdings Inc. · on record since Sep 25, 2018
- 10% owner at Morphic Holding, Inc. · on record since Jun 26, 2019
- 10% owner at Milestone Pharmaceuticals Inc. · on record since May 14, 2019
- 10% owner at Mirum Pharmaceuticals, Inc. · on record since Jul 23, 2019
- 10% owner at Inozyme Pharma, Inc. · on record since Jul 29, 2020
- 10% owner at Harmony Biosciences Holdings, Inc. · on record since Aug 25, 2020
- 10% owner at Nkarta, Inc. · on record since Jul 16, 2020
- 10% owner at Checkmate Pharmaceuticals, Inc. · on record since Aug 13, 2020
- 10% owner at Damora Therapeutics, Inc. · on record since Oct 28, 2020
- 10% owner at Aligos Therapeutics, Inc. · on record since Oct 22, 2020
- 10% owner at HEARUSA INC · on record since Oct 22, 2020
- 10% owner at Praxis Precision Medicines, Inc. · on record since Oct 21, 2020
- 10% owner at Galera Therapeutics, Inc. · on record since Oct 19, 2020
- 10% owner at SPRUCE BIOSCIENCES, INC. · on record since Oct 16, 2020
- 10% owner at Edgewise Therapeutics, Inc. · on record since Mar 31, 2021
- 10% owner at BOLT TECHNOLOGY CORP · on record since Feb 11, 2021
- 10% owner at MINERVA SURGICAL INC · on record since Oct 27, 2021
- 10% owner at IO Biotech, Inc. · on record since Nov 10, 2021
- 10% owner at Arcellx, Inc. · on record since Feb 9, 2022
- 10% owner at Disc Medicine, Inc. · on record since Jan 3, 2023
Insider trading activity of Novo A/S
- Transactions on record
- 903
- since Feb 2, 2007
- Open-market buys
- 609
- $344.8M
- Open-market sells
- 115
- $491.3M
- Companies traded
- 46
- last filing May 6, 2026
Figures computed from official regulatory filings — methodology.
Companies where Novo A/S has traded
- Hemab Therapeutics Holdings, Inc.5 tx · May 6, 2026
- Avalyn Pharma Inc.7 tx · $10M · May 5, 2026
- MapLight Therapeutics, Inc.4 tx · $16.2M · Oct 30, 2025
- IO Biotech, Inc.10 tx · $16.5M · Jul 26, 2024
- SPRUCE BIOSCIENCES, INC.12 tx · $20.8M · Mar 25, 2024
- Metagenomi Therapeutics, Inc.5 tx · $13M · Feb 15, 2024
- CYTEC INDUSTRIES INC/DE/22 tx · $8.8M · Jul 20, 2023
- Disc Medicine, Inc.1 tx · $57.6M · Jun 28, 2023
- OnKure Therapeutics, Inc.4 tx · $10.7M · Jun 23, 2023
Track record of Novo A/S
Statistical track record
Free- Open-market buys
- 611
- Last buy
- May 1, 2026
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of Novo A/S
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
6 tx · $15M · Sep 16, 2022
NEA Partners 15, L.P.Arcellx, Inc. +4
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| May 6, 2026 | OtherD | -62,121 | 0.00 USD | $0 | SEC |
| May 6, 2026 | Other | 4,180,550 | — | — | SEC |
| May 6, 2026 | OtherD | -71,866 | 0.00 USD | $0 | SEC |
| May 6, 2026 | OtherD | -32,695 | 0.00 USD | $0 | SEC |
| May 6, 2026 | OtherD | -23,343 | 0.00 USD | $0 | SEC |
| May 5, 2026 | OtherD | -25,899,284 | 0.00 USD | $0 | SEC |
| May 5, 2026 | OtherD | -18,000,000 | 0.00 USD | $0 | SEC |
| May 5, 2026 | Other | 3,327,734 | — | — | SEC |
| May 5, 2026 | Buy | 555,555 | 18.00 USD | $10M | SEC |
| May 5, 2026 | OtherD | -5,587,603 | 0.00 USD | $0 | SEC |
| May 5, 2026 | OtherD | -12,558,081 | 0.00 USD | $0 | SEC |
| May 5, 2026 | OtherD | -1,986,369 | 0.00 USD | $0 | SEC |
| Oct 30, 2025 | Buy | 952,941 | 17.00 USD | $16.2M | SEC |
| Oct 30, 2025 | OtherD | -26,191,207 | 0.00 USD | $0 | SEC |
| Oct 30, 2025 | Other | 2,733,681 | — | — | SEC |
| Oct 30, 2025 | OtherD | -19,734,671 | 0.00 USD | $0 | SEC |
| Jul 26, 2024 | Sell | -23,478 | 1.31 USD | $30.8K | SEC |
| Jul 26, 2024 | Sell | -51,522 | 1.33 USD | $68.5K | SEC |
| May 14, 2024 | Sell | -658,809 | 1.22 USD | $803.7K | SEC |
| Mar 25, 2024 | Sell | -465,021 | 0.75 USD | $348.8K | SEC |
| Mar 20, 2024 | Sell | -842,020 | 0.77 USD | $648.4K | SEC |
| Mar 20, 2024 | Sell | -359,979 | 0.73 USD | $262.8K | SEC |
| Mar 20, 2024 | Sell | -593,000 | 0.76 USD | $450.7K | SEC |
| Mar 18, 2024 | Sell | -1,912,316 | 0.89 USD | $1.7M | SEC |
| Feb 15, 2024 | Buy | 800,000 | 15.00 USD | $12M | SEC |